This inventor holds 1 USPTO granted patent. Top assignee: University of Manitoba. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations in Vaccine Development by Xiao-Jian Yao
Introduction
Xiao-Jian Yao is a prominent inventor based in Winnipeg, Canada. He has made significant contributions to the field of vaccine development, particularly in creating innovative solutions for influenza infections. His work focuses on utilizing advanced technologies to enhance vaccine efficacy and broaden their applicability.
Latest Patents
Xiao-Jian Yao holds a patent for a "Dendritic cell-targeting universal vaccine for influenza infection." This novel vaccine platform employs Ebola glycoprotein (EboGP) DC-targeting domain-based fusion protein technology. The aim is to generate universal vaccines against Influenza A by fusing a DC-targeting/activation domain derived from EboGP to various components of the influenza virus, including the conserved extracellular domain of M2 and the HA head regions polypeptides from different strains.
Career Highlights
Xiao-Jian Yao is affiliated with the University of Manitoba, where he conducts research and develops innovative vaccine technologies. His work has garnered attention for its potential to revolutionize how vaccines are designed and implemented, particularly in response to evolving viral threats.
Collaborations
Due to space constraints, the details of collaborations will not be included.
Conclusion
Xiao-Jian Yao's contributions to vaccine development exemplify the innovative spirit of modern science. His work on dendritic cell-targeting vaccines represents a significant advancement in the fight against influenza infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile